Profile data is unavailable for this security.
About the company
Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
- Revenue in SEK (TTM)11.10m
- Net income in SEK-182.48m
- Incorporated2007
- Employees83.00
- LocationQ linea ABDag Hammarskjolds Vag 52 AUPPSALA 752 37SwedenSWE
- Phone+46 184443610
- Websitehttps://www.qlinea.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INIFY Laboratories AB | 20.14m | -61.42m | 307.97m | 34.00 | -- | 2.35 | -- | 15.29 | -1.13 | -1.13 | 0.3664 | 1.70 | 0.1928 | 2.96 | 3.12 | 848,737.60 | -58.78 | -- | -58.78 | -- | 85.20 | -- | -304.93 | -- | -- | -- | 0.00 | -- | 1,000.67 | -- | 3.15 | -- | -- | -- |
| Acarix AB | 7.36m | -48.09m | 319.02m | 8.00 | -- | 8.67 | -- | 43.35 | -0.0427 | -0.0427 | 0.0065 | 0.0328 | 0.114 | 0.1658 | 3.37 | -- | -74.50 | -80.03 | -84.46 | -94.19 | 84.74 | 83.62 | -653.38 | -1,091.79 | 3.45 | -623.52 | -- | -- | 18.69 | 27.67 | 27.34 | -- | -- | -- |
| Ortoma AB | 77.19m | -7.52m | 416.18m | 10.00 | -- | 2.64 | 79.70 | 5.39 | -0.2027 | -0.2027 | 2.08 | 4.45 | 0.4243 | 3.95 | 39.13 | 7,530,537.00 | -4.13 | -9.37 | -4.45 | -10.43 | 41.26 | 158.24 | -9.74 | -78.90 | 3.02 | -- | 0.00 | -- | 28.77 | -- | 46.83 | -- | -0.5751 | -- |
| Mentice AB | 274.49m | -43.31m | 431.73m | 121.00 | -- | 3.43 | -- | 1.57 | -1.68 | -1.68 | 10.52 | 4.48 | 0.9663 | 1.60 | 3.94 | 2,095,328.00 | -15.25 | -6.64 | -31.60 | -11.91 | 90.40 | 84.80 | -15.78 | -8.53 | 0.845 | -30.10 | 0.116 | -- | 6.11 | 14.22 | -553.89 | -- | 32.86 | -- |
| Q linea AB | 11.10m | -182.48m | 465.77m | 83.00 | -- | 1.38 | -- | 41.97 | -35.87 | -35.87 | 1.31 | 17.84 | 0.0429 | 0.4006 | 2.90 | -- | -70.50 | -76.00 | -101.81 | -93.84 | -15.26 | -145.47 | -1,644.30 | -2,820.51 | 10.04 | -30.48 | 0.017 | -- | 369.86 | 114.75 | 15.86 | -- | -34.47 | -- |
| Modulight Oyj | 75.41m | -49.11m | 506.44m | 71.00 | -- | 1.06 | -- | 6.72 | -0.12 | -0.12 | 0.1874 | 1.05 | 0.1341 | -1.01 | 4.54 | -- | -8.73 | -11.40 | -9.39 | -12.14 | 132.06 | 125.90 | -65.10 | -126.56 | 3.79 | -- | 0.0588 | -- | 72.63 | -6.82 | 28.59 | -- | 15.83 | -- |
| Bactiguard Holding AB | 228.77m | -7.84m | 540.16m | 153.00 | -- | 1.94 | 13.77 | 2.36 | -0.2238 | -0.2238 | 6.53 | 8.99 | 0.381 | 3.44 | 6.91 | 1,495,216.00 | -1.31 | -8.02 | -1.86 | -10.13 | 63.78 | 48.56 | -3.43 | -25.10 | 1.38 | -0.3387 | 0.3410 | -- | -12.64 | 4.22 | 73.69 | -- | -17.92 | -- |
| Gentian Diagnostics ASA | 167.55m | 12.58m | 578.28m | 63.00 | 46.70 | 2.97 | 27.23 | 3.45 | 0.8459 | 0.8459 | 11.35 | 13.29 | 0.7231 | 1.56 | 6.36 | -- | 5.43 | -0.0483 | 6.25 | -0.055 | 55.64 | 47.27 | 7.51 | -0.0788 | 3.81 | -- | 0.0866 | -- | 16.07 | 22.75 | -70.73 | -- | 10.72 | -- |
| Optomed Oyj | 182.36m | -70.83m | 612.18m | 111.00 | -- | 2.39 | -- | 3.36 | -0.3374 | -0.3374 | 0.8688 | 1.12 | 0.5363 | 2.87 | 5.07 | 154,009.00 | -20.83 | -17.19 | -25.75 | -20.69 | 63.60 | 64.81 | -38.85 | -34.21 | 2.03 | -8.91 | 0.1014 | -- | 13.67 | 5.61 | -21.83 | -- | 5.30 | -- |
| BioPorto A/S | 52.20m | -123.91m | 639.68m | 48.00 | -- | 11.70 | -- | 12.26 | -0.1973 | -0.1973 | 0.083 | 0.0774 | 0.4132 | 2.55 | 4.69 | 962,131.60 | -98.08 | -65.22 | -133.92 | -88.74 | 63.90 | 64.15 | -237.40 | -222.22 | 1.71 | -- | 0.1916 | -- | 17.07 | 6.36 | -21.15 | -- | -20.56 | -- |
| Nanexa AB | 36.15m | -11.39m | 655.87m | 15.00 | -- | 6.39 | 570.32 | 18.14 | -0.0724 | -0.0724 | 0.2255 | 0.6237 | 0.3144 | 16.22 | 5.23 | 2,409,933.00 | -9.90 | -31.63 | -12.96 | -38.78 | 86.02 | 96.94 | -31.50 | -218.01 | 1.51 | -3.21 | 0.0109 | -- | 48.39 | 72.50 | 54.27 | -- | 3.54 | -- |
Data as of Feb 27 2026. Currency figures normalised to Q linea AB's reporting currency: Swedish Krona SEK
2.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 21 Feb 2025 | 200.05k | 1.06% |
| Handelsbanken Fonder ABas of 31 Dec 2025 | 114.38k | 0.60% |
| Storebrand Asset Management ASas of 31 Jan 2026 | 101.82k | 0.54% |
| Investment AB �resund (Investment Management)as of 31 Dec 2024 | 55.61k | 0.29% |
| SEB Funds ABas of 29 Jan 2025 | 766.00 | 0.00% |
| FCG Fonder ABas of 31 Mar 2025 | 618.00 | 0.00% |
| Danske Bank A/S (Investment Management)as of 31 Jan 2026 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2024 - 31 Jan 2026Source: FactSet Research Systems Inc.
